News

The potential to produce cheaper medicines on a large scale within edible plants including lettuce and canola has taken a significant step forward with new findings led by researchers from La Trobe University with collaborators at The University of Queensland. 

Researchers have shown why a fragment of a protein from the venom gland of rattlesnakes could be the basis for an alternative to conventional antibiotics.

More targeted and effective treatments for some of the world’s most complex diseases in humans may be a step closer, thanks to research that better maps disease susceptibility to genes and DNA.

Spider webs are made from silk. And silk is made from something scientists call “proteins”. Proteins are special chemicals made by a living thing - like an animal or a plant. You have lots of them in your body. Proteins usually have a certain job to do.

Respiratory infection is the sixth-leading cause of death in Australia, and bacteria are becoming resistant to the antibiotics used to treat these diseases.

90 seconds with PhD student Amy Chan

The Queensland Women in STEM Prize showcases inspiring early- to mid-career females working in STEM fields whose practice has the potential to benefit Queensland and who engage and communicate with the broader community. To vote for an IMB researcher for the People's Choice Award, and to check out how these young scientists are using life itself to change the world, please click on the images below to vote.

Venom researchers from the Institute for Molecular Bioscience (IMB) have discovered the venom of the assassin bug is like no other venomous animal previously studied.

Therapeutics inspired by venoms could provide the key to treatment for a common gastrointestinal disease if a collaboration between researchers from Institute for Molecular Bioscience and Danish biotech company Zealand Pharma A/S is successful.

A joint University of Queensland and Queensland Health-led team has completed the first genetic analysis of TB strains circulating on PNG’s Daru Island, a major hotspot for TB outbreaks on Australia’s doorstep.

Humans might be the most resilient species on Earth, but until recently, no one could explain how a small population survives the incredibly harsh conditions of the Tibetan Plateau – a lofty, oxygen-starved environment that towers 4.5 km above sea level.

A discovery by Queensland scientists could be the key to stopping damage caused by uncontrolled inflammation in a range of common diseases including liver disease, Alzheimer’s and gout.

Researchers say a major genomic study will provide answers for patients with unexplained kidney disease, and could lead to better treatments.

The Institute for Molecular Bioscience (IMB) has celebrated the graduations of its first PhD students from Serbia and Nepal, who investigated rare neurodegenerative disorders and diagnostic tools for dengue fever.

The Director of The University of Queensland’s Institute for Molecular Bioscience (IMB) will help steer a national initiative striving to double survival rates for people with brain cancer over the next decade.

In the “golden era” of antibiotic drug discovery – 1950 to 1970 – drug companies could afford to be choosy, selecting only the very best candidates for approval.As a result, many potent antibiotics did not make the cut for development and were abandoned. Given the current crisis in antibiotic discovery, the time is right to revisit many of these potentially invaluable molecules in search of antibiotic scaffolds with novel modes of action.

An antibiotic overlooked since its discovery 40 years ago could help develop new drugs against life-threatening infections caused by some of the world’s most dangerous superbugs.

You know the drill. A picnic in the park, a walk in the bush or a barbecue with friends and family – all perfect summer activities that can be ruined by annoying flies that never leave you alone.

So why do they do it and what do they want?

Did you know that when you take certain genetic tests, the company can make money by on-selling your data to other businesses?

Now new blockchain-based marketplaces could give individuals control over access to their encrypted DNA data, and the ability to sell it to research companies for their own profit.